Gmo-Z.Com Research Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.03 Cr
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.86%
- Profit Growth -81.45%
- Ebitda -78.33%
- Net Worth 4.20%
- Total Assets 14.95%
About Gmo-Z.Com Research
Gmo-Z.Com Research Private Limited (GRPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 26 November 2013 and has a history of 11 years and two months. Its registered office is in New Delhi, Delhi, India.
The Corporate was formerly known as Gmo Research Private Limited. The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shinichi Hosokawa, Yusuke Nagasawa, and Takenori Mori serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200DL2013FTC261014
- Company No.
261014
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
26 Nov 2013
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Gmo-Z.Com Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shinichi Hosokawa  | Managing Director | 26-Nov-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Takenori Mori | Director | 25-Oct-2021 | Current |
| Yusuke Nagasawa | Whole-Time Director | 11-Jul-2024 | Current |
Financial Performance of Gmo-Z.Com Research.
Gmo-Z.Com Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.86% increase. The company also saw a substantial fall in profitability, with a 81.45% decrease in profit. The company's net worth moved up by a moderate rise of 4.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gmo-Z.Com Research?
In 2023, Gmo-Z.Com Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gmo-Z.Com Research?
Gmo-Z.Com Research has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gmo-Z.Com Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gmo-Z.Com Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
